HER2 positive - Globe Thesis

Keyword [HER2 positive] Result: 121 - 140 \| Page: 7 of 8
121.	Influencing Factors And Predictors Of Effect Of Pathological Complete Response Of HER2-positive Breast Cancer Treated With Neoadjuvant Treatment And Mechanism Of Drug Resistance
122.	Mechanisms Underlying The Role Of RSK2 In Promoting The Proliferation And Migration In HER2 Positive Breast Cancer Cells
123.	Risk Factors Analysis And Prediction Model For Brain Metastasis Of HER2 Positive Breast Cancer
124.	A Study Of The Effectiveness And Its Mechanism Of Shenling Baizhu Power In Treating Pyrotinib-induced Diarrhea In HER2-positive Breast Cancer
125.	The Expression And Functional Identification Of A HER2-Targeted Immunopyroptotic Molecule
126.	Efficacy And Safety Of T-DM1 In The Treatment Of HER2 Positive Breast Cancer: A Systematic Review And Meta-analysis
127.	A Real-world Study Of Pyrotinib In The Treatment Of HER2-positive Advanced Breast Cancer
128.	The Inhibitory Effect And Mechanism Of Huaier Aqueous Extract On HER2 Positive Breast Cancer Cell SKBR3 With Overexpressed MYCN
129.	Clinical Significance And Basic Research Of PIK3CA Mutations In HER2 Positive Breast Cancer
130.	Prognostic Model Construction Of HER2-positive Gastric Cancer And Systematic Treatment Meta-analysis
131.	Enhancing ADCC Effect To Improve The Efficacy Of Trastuzumab In The Treatment Of HER2 Positive Breast Cancer
132.	The Mechanisms And Roles Of Abnormally Activated IGF2/IGF-1R/IRS1 Signaling In Herceptin Resistance Of Breast Cancer
133.	Efficacy And Safety Of Pyrotinib-Based Regimens In HER2 Positive Metastatic Breast Cancer:A Retrospective Real-World Data Study
134.	Efficacy Of Zercepac^? Compared With Herceptin^? Combined With Pertuzumab In Neoadjuvant Therapy For HER2 Positive Breast Cancer
135.	Construction And Validation Of A Predictive Model Of Pathological Complete Response Combined With MRI And Tumor Indicators For HER2-positive Breast Cancer After Neoadjuvant Targeted Therapy
136.	Study On The Inhibitory Effect Of Trastuzumab Combined With Nab-paclitaxel On HER2-positive Gastric Cancer
137.	Using TCGA Database To Establish A Risk Prediction Model Of Drug Resistance In HER2 Positive Breast Cancer Patients After Targeted Therapy Based On Ferroptosis
138.	Efficacy Analysis Of Trastuzumab Combined With Pertuzumab In The Third-Line Treatment Of HER2-Positive Breast Cancer And The Value Of SOX11 In Predicting Its Efficacy
139.	Herceptin Functionalized SK-BR-3 Cell Membrane Wrapped Paclitaxel Nanocrystals For Enhancing The Targeted Therapy Effect Of HER2-positive Breast Cancer
140.	Comparison Of Neoadjuvant Trastuzumab Combined With Pyrotinib/pertuzumab In The Treatment Of HER2 Positive Breast Cancer
<<First <Prev Next> Last>> Jump to